Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01669980 · ClinicalTrials.gov registry record · Phase 4
Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)
A Phase 4 study, sponsored by Forest Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT01669980 is a Phase 4 study that has completed, run by Forest Laboratories. The registered enrollment target is 40 participants.
The verdict
NCT01669980, a Phase 4 study, has completed, sponsored by Forest Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
This is a study of safety and effectiveness of ceftaroline fosamil in children with Complicated Community-acquired Pneumonia receiving antibiotic therapy in the hospital.
Interventions
- DRUG Ceftaroline fosamil
- DRUG IV Ceftriaxone and Vancomycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2012-10 |
| Est. Completion | 2014-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01669980
The ClinicalTrials.gov registry entry for NCT01669980 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Forest Laboratories, which has 145 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ceftaroline fosamil is the first listed.
NCT01669980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01669980 about?
NCT01669980 is a clinical study titled "Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)". This is a study of safety and effectiveness of ceftaroline fosamil in children with Complicated Community-acquired Pneumonia receiving antibiotic therapy in the hospital.
What is the current status of trial NCT01669980?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2012-10. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01669980?
The interventions under investigation include: Ceftaroline fosamil (DRUG), IV Ceftriaxone and Vancomycin (DRUG).
Who is sponsoring clinical trial NCT01669980?
This trial is sponsored by Forest Laboratories, which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.